Amphetamine and related compounds have previously been shown to differ
entially release dopamine (DA) and serotonin (5HT) in vivo and in vitr
o. The purpose of this report is directly to compare five amphetamine
analogs on differential reinforcement of low rate 36-s (DRL 36-s) sche
dule performance, and to determine whether the reported increases in d
opamine and/or serotonin release induced by these drugs can be related
to observed behavioral differences. Amphetamine (AMPH) and methamphet
amine (METH) induced large increases in response rate, methylenedioxym
ethamphetamine (MDMA) and para-chloroamphetamine (PCA) caused small in
creases in response rate, while fenfluramine (FEN) had no effect on re
sponse rate. AMPH, METH, PCA and MDMA caused a dose-dependent decrease
in reinforcement rate, and FEN had no effect on reinforcement rate. A
MPH, METH, and PCA but not FEN, shifted the peak of the inter-response
time (IRT) distribution toward shorter intervals, MDMA decreased peak
location only at the highest dose. All five drugs caused a dose-depen
dent decrease in peak area, indicating a loss of schedule control on t
he DRL 36-s schedule. Consistent with in vitro and in vivo release stu
dies, the differential results of these five drugs on DRL 36-s schedul
e performance suggest a predominant dopamine role for AMPH and METH, a
predominant serotonin role for FEN, and different degrees of combined
dopaminergic and serotonergic roles for MDMA and PCA in the mediation
of the task.